Rossari Biotech Schedules Board Meeting on 17th Oct'26 to Approve Q2 Results
Rossari Biotech Ltd 路 Intimation 路 17 Oct 2026, 5:30 am
Rossari Biotech Schedules Board Meeting on 17th Oct'26 to Approve Q2 Results Rossari Biotech Limited announced that its Board of Directors will meet on 17th Oct'26 to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended 30th Sep'26. Additionally, the trading window for dealing in company securities remains closed for designated persons and their immediate relatives from 1st Oct'26 until 48 hours after the declaration of the financial results.
Original exchange filing (PDF)
More announcements from Rossari Biotech Ltd
- Intimation of Transcript of Q2 & H1 FY27 for the Earnings Conference Call held on October 19, 2026 路 23 Oct 2026
- Audio recording of Earnings Conference Call for Q2 & H1 FY 27. 路 20 Oct 2026
- Press Release for Q2 FY27 Results 路 19 Oct 2026
- Intimation of Q2 & H1 FY27- Earnings Presentation 路 19 Oct 2026
- Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Half year ended September 30, 2026. 路 18 Oct 2026
- Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 路 18 Oct 2026
- Outcome of Board Meeting held on October 17, 2026. 路 18 Oct 2026
- Outcome of Board Meeting Held On October 17, 2026 路 18 Oct 2026
